Skip to content
← All stacks

Stack · Cognition & Mood

Cognitive / Nootropic Stack (Semax + Selank + Dihexa)

Also searched as: cognitive stack, russian nootropic stack, calm focus stack, semax + selank, semax selank dihexa

A "brain peptide" combo marketed for focus, calm and memory: Semax for drive, Selank for anxiety, and Dihexa for synapse-building. Semax and Selank are Grade C (Russian-registered drugs with some human data); Dihexa is Grade D, with no human trials at all.

D

The verdict

Mixed evidence: the weakest link is Grade D — animal data only.

Stacking peptides doesn't combine their evidence — it combines their unknowns. A stack is only as proven as its members.

01What is it?

This isn't one product, it's a DIY combination of three peptides aimed at the brain. Semax (a synthetic fragment of ACTH) and Selank (a synthetic analogue of the immune peptide tuftsin) were both developed in Russia in the 1980s-90s and are registered medicines there, usually as nasal sprays. Dihexa is a newer, lab-made analogue of angiotensin IV from Washington State University research. The trio is a biohacker/seller construction, not a clinically studied protocol: the idea is that each one covers a different angle — Semax for cognition, Selank for calm, Dihexa for wiring new connections.

02Why it's hyped

The sales story divides the labour neatly. Semax is pitched as the pro-cognitive, "Miracle-Gro for the brain" peptide that raises BDNF and sharpens focus and memory. Selank is marketed as anti-anxiety without the sedation or dependence of benzodiazepines — the "calm" half of "calm focus". Dihexa gets billed as a synapse-builder, often with the claim that it's many orders of magnitude more potent than BDNF at growing new connections. Put together, vendors and clinics sell it as a complete "focused calm" package: drive plus mood plus rewiring.

03The honest take

Look at the grades before you look at the marketing. Semax and Selank are Grade C: they're real registered drugs in Russia with some human use behind them, but the Western evidence base is thin and the glossy "BDNF badass" claims run well ahead of what's actually been shown in good trials. Dihexa is the weak link — Grade D, with published evidence that is entirely preclinical. There are no completed human clinical trials on Dihexa itself; the "more potent than BDNF" line comes from cell cultures and rats, and one of the headline papers behind it has since been retracted. Stacking a couple of lightly-evidenced peptides with one that has no human data doesn't give you a guaranteed cognitive edge — it's an experiment you're running on yourself. And the people telling you it's "synergistic" are usually the ones selling the vials.

04What's actually in it

05Is it legal in the UK?

None of the three is a licensed medicine in the UK. Semax and Selank are approved only in Russia (and a few neighbouring countries) and have never been through the MHRA or EMA; Dihexa has no approval anywhere. In the UK all three are sold as unlicensed "research chemicals", meaning no regulator has checked what's actually in the bottle, the purity, or the dose.

Last reviewed: 2026-06

WTPWhat's That Peptide?

The honest, UK guide to research peptides. We index the evidence, explain the mechanisms, and grade every one by a single question: how much do we actually know in humans?

Our promise

  • Nothing for sale
  • No money from vendors
  • No dosing, ever
  • Every claim cited

The honest brief

Occasional. Honest. Never for sale.

New entries, grade changes and the odd reality check — no spam.

Not medical advice. An educational reference about research peptides for a UK audience. Most peptides here are not licensed medicines in the UK, and nothing on this site tells you to obtain, possess or use any substance. Talk to a qualified clinician before any health decision. Read the full disclaimer.

© 2026 What's That Peptide

Built by stumason.dev